As of 2025-07-14, the EV/EBITDA ratio of WAVE Life Sciences Ltd (WVE) is -7.92. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. WVE's latest enterprise value is 943.73 mil USD. WVE's TTM EBITDA according to its financial statements is -119.10 mil USD. Dividing these 2 quantities gives us the above WVE EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 0.4x - 0.7x | 0.6x |
| Forward P/E multiples | 0.4x - 0.7x | 0.6x |
| Fair Price | 1.24 - 1.07 | 1.15 |
| Upside | -83.9% - -86.1% | -85.0% |
| Date | EV/EBITDA |
| 2025-07-14 | -8.10 |
| 2025-07-11 | -7.92 |
| 2025-07-10 | -8.25 |
| 2025-07-09 | -7.92 |
| 2025-07-08 | -6.95 |
| 2025-07-07 | -7.10 |
| 2025-07-03 | -6.95 |
| 2025-07-02 | -6.69 |
| 2025-07-01 | -6.39 |
| 2025-06-30 | -6.37 |
| 2025-06-27 | -6.59 |
| 2025-06-26 | -7.06 |
| 2025-06-25 | -6.82 |
| 2025-06-24 | -6.80 |
| 2025-06-23 | -6.97 |
| 2025-06-20 | -6.46 |
| 2025-06-18 | -6.89 |
| 2025-06-17 | -6.49 |
| 2025-06-16 | -6.82 |
| 2025-06-13 | -6.95 |
| 2025-06-12 | -7.28 |
| 2025-06-11 | -7.26 |
| 2025-06-10 | -7.32 |
| 2025-06-09 | -7.08 |
| 2025-06-06 | -7.30 |
| 2025-06-05 | -6.69 |
| 2025-06-04 | -6.60 |
| 2025-06-03 | -6.37 |
| 2025-06-02 | -6.05 |
| 2025-05-30 | -5.74 |
| 2025-05-29 | -6.03 |
| 2025-05-28 | -5.79 |
| 2025-05-27 | -5.65 |
| 2025-05-23 | -5.66 |
| 2025-05-22 | -5.84 |
| 2025-05-21 | -5.78 |
| 2025-05-20 | -6.42 |
| 2025-05-19 | -6.32 |
| 2025-05-16 | -6.15 |
| 2025-05-15 | -6.11 |
| 2025-05-14 | -6.18 |
| 2025-05-13 | -6.23 |
| 2025-05-12 | -6.50 |
| 2025-05-09 | -6.48 |
| 2025-05-08 | -6.42 |
| 2025-05-07 | -6.36 |
| 2025-05-06 | -6.25 |
| 2025-05-05 | -7.96 |
| 2025-05-02 | -8.44 |
| 2025-05-01 | -8.23 |